Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic. Example: Methyleugenol, CASRN: 93-15-2

Food and Chemical Toxicology

Volumn 48, Issue SUPPL. 1, 2010, Pages

  Smith, Benjamin ^a   Cadby, Peter ^a   Leblanc, Jean Charles ^b   Setzer, R Woodrow ^c  

^a Analysis and Perception Department   (Switzerland)

^b French Food Safety Agency   (France)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Margin of exposure; Methyleugenol; MoE

Indexed keywords

METHYLEUGENOL;

ARTICLE; CARCINOGENICITY; DOSE RESPONSE; FOOD INTAKE; FOOD POISONING; GENOTOXICITY; HUMAN; LIVER ADENOMA; LIVER CARCINOMA; MARGIN OF EXPOSURE; MATHEMATICAL ANALYSIS; NONHUMAN; QUALITY CONTROL; TOXICITY TESTING;

ANIMALS; CARCINOGENS; DATA INTERPRETATION, STATISTICAL; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; EUGENOL; FEMALE; FOOD CONTAMINATION; HUMANS; MALE; MICE; MODELS, STATISTICAL; MUTAGENS; NEOPLASMS; RATS;

RATTUS;

EID: 74549209801     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.10.036     Document Type: Article

References (55)

1. Anthony A., Caldwell J., Hutt A.J., and Smith R.L. Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole. Food Chem. Toxicol. 25 (1987) 799-806
2. Benedetti M.S., Malnoe A., and Broillet A.L. Absorption, metabolism and excretion of safrole in the rat and man. Toxicology 7 1 (1977) 69-83
3. Boberg E.W., Miller E.C., Miller J.A., Poland A., and Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res. 43 11 (1983) 5163-5173
4. Bobin, M.F., Gau, F., Pelltier, J., Cotte, J., 1991. Etude de L'Arome Basilic. Rivista Ital., EPPOS 3-13.
5. Burkey J.L., Hoglen N.C., Kattnig M.J., Rice M.E., and Sipes I.G. The in vivo disposition and metabolism of methyleugenol in the Fischer 344 rat and the B6C3F1 mouse. Toxicologist 48 1-S (1999) 224
6. Caldwell J., Chan V.S.W., Marshall A.D., Hasheminejad G., and Bounds S.V.J. 1′-Hydroxylation is the only metabolic pathway of simple alkenylbenzenes involved in their genotoxicity. Toxicologist 12 1 (1992) 56
7. Chan V.S.W., and Caldwell J. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1′-hydroxy metabolites. Food and Chemical Toxicology 30 (1992) 831-836
8. Council of Europe, 2001a. Use Levels of Methyleugenol Provided by Source Materials Containing Methyleugenol. Document Submitted by IOFI (22.03.2000) RD 4.9/1.46, unpublished.
9. Council of Europe, 2001b. Committee of Experts on Flavouring Substances. Note on the Method used to Calculate Intake Estimates. Document RD 4.11/1-48 Submitted by the Delegation of UK for the 48th Meeting in Strasbourg, April 2001.
10. Daimon H., Sawada S., Asakura S., and Sagami F. In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole. Carcinogenesis 19 1 (1998) 141-146
11. Dorange J.L., Delaforge M., Janiaud P., and Padieu P. Mutagenicity of the metabolites of the epoxide diol pathway of safrolee and analogs. Study on Salmonella typhimurium. Societe de Biologie de Dijon 171 (1977) 1041-1048
12. Drinkwater N.R., Miller E.C., Miller J.A., and Pitot H.C. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′-hydroxyestragole in the mouse and mutagenicity of 1′-acetoestragole in bacteria. J. Natl. Cancer Inst. 57 (1976) 1323-1331
13. European Commission (EC), 2008. Common position (EC) No. 9/2008 adopted by the council on 10 March 2008. Official Journal of the European Union, C111E/46 on 6.5.2008, annex III. .
14. European Food Safety Authority (EFSA), 2004. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a Request from the Commission Related to Coumarin. .
15. Gardner, I., Bergin, P., Stening, P., Kenna, J.G., Caldwell, J., 1995. Protein adducts derived from methyleugenol. In: Meeting Report of the 4th International ISSX Meeting, vol. 8. International Society for the Study of Xenobiotics, Washington, DC, USA, p. 208.
16. Gardner I., Bergin P., Stening P., Kenna J.G., and Caldwell J. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Crit. Rev. Toxicol. 9 4 (1996) 713-721
17. Gardner I., Wakazono H., Bergin P., de Waziers I., Beaune P., Kenna J.G., and Caldwell J. Cytochrome P450 mediated bioactivation of methyleugenol to 1′-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes. Carcinogenesis 18 (1997) 1775-1783
18. Gavin C.L., Williams M.C., and Hallagan J.B. FEMA Poundage and Technical Effects Update Survey (2007), Flavor and Extract Manufacturers Association, Washington, DC, USA
19. Green C.L., and Espinosa F. Jamaican and Central American Pimento (Allspice; Pimenta dioica): characterization of flavour differences and other distinguishing features. In: Lawrence B.M., Mookherjee B.D., and Willisand B.J. (Eds). Flavours and Fragrances: A World Perspective (1988), Elsevier, Amsterdam 3-20
20. Hasheminejad G., and Caldwell J.J. Genotoxicity of the alkenylbenzenes alpha- and beta-asarone, myristicin and elemicin as determined by the USD assay in cultured hepatocytes. Food Chem. Toxicol. 3 22 (1994) 223-231
21. Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2008. In: 69th Meeting, 17-26 June 2008, Rome, Italy, Summary and Conclusions: 3.1.10 Alkoxy-Substituted Allylbenzenes Present in Foods and Essential Oils and used as Flavouring Agents. .
22. Jeurissen S.M.F., Bogaards J.J.P., Boersma M.G., ter Horst J.P.F., Awad H.M., Fiamegos Y.C., van Beek T.A., Alink G.M., Sudhölter E.J.R., Cnubben N.H.P., and Rietjens I.M.C.M. Human cytochrome P450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1′-hydroxymethyleugenol. Chem. Res. Toxicol. 19 1 (2006) 111-116
23. Jeurissen S.M.F., Punt A., Delatour T., and Rietjens I.M.C.M. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1′-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. Food Chem. Toxicol. 46 (2008) 2296-2302
24. Lawrence, B.M., 1994. R.J. Reynolds Tobacco Co., Winston-Salem, N.C. Is the development of an essential oil industry in Malaysia a viable commercial opportunity? In: Lawence, B.M. (Ed.), Essential Oils, Allured Publishing Corporation, Carol Stream, IL, pp. 187-204.
25. Lawrence M., and Shu C.K. Essential oils as components of mixtures: their method of analysis and differentiation. In: Ho C.T., and Manley C.M. (Eds). Flavor Measurement (1993), Marcel Dekker, New York
26. Miele M., Dondero R., Ciarallo G., and Mazzei M. Methyleugenol in Ocimum basilicum L. Cv, Genovese Gigante. J. Agric. Food Chem. 49 (2001) 517-521
27. Miller J.A., Miller E.C., and Phillips D.H. The metabolic activation and carcinogenicity of alkenylbenzenes that occur naturally in many spices. Carcinogens Mutagens Environ. 1 (1982) 83-96
28. Miller E.C., Swanson A.B., Phillips D.H., Fletcher T.L., Liem A., and Miller J.A. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 43 (1983) 1124-1134
29. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., and Zeiger E. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutat. 8 Suppl. 7 (1986) 1-119
30. Müller L., Kasper P., Müller-Tegethoff K., and Petr T. The genotoxic potential in vitro and in vivo of the allyl benzene etheric oils estragole, basil oil and trans-anethole. Mutat. Res. 325 (1994) 129-136
31. Nijssen, B., van Ingen-Visscher, K., Donders, J., 2008. VCF (Volatile Compounds in Foods) Database. TNO Nutrition and Food Research, Zeist, Netherlands. version 10.1 accessed.
32. National Toxicology Program (NTP), 1998. Toxicology and Carcinogenesis Studies of Methyleugenol (CAS No. 93-15-12) in F344/N Rats and B6C3F1 Mice (Gavage Studies). DRAFT NTP-TR-491. NIH Publication No. 98-3950.
33. National Toxicology Program (NTP), 2000. Toxicology and Carcinogenesis Studies of Methyleugenol (CAS No. 93-15-12) in F344/n Rats and B6C3F1 Mice (gavage studies). DRAFT NTP-TR-491. NIH Publication No. 98-3950.
34. National Toxicology Program (NTP), 2002. Tenth Report on carcinogens, Eleventh Edition Methyleugenol (CAS No. 93-15-12).
35. Phillips D.H., Reddy M.V., and Randerath K. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrolee, estragole and other naturally-occurring alkenylbenzenes II. Newborn male B6C3F1 mice. Carcinogenesis 5 (1984) 1623-1628
36. Punt A., Freidig A.P., Delatour T., Scholz G., Boersma M.G., Schilter B., van Bladeren P.J., and Rietjens I.M. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat. Toxicol. Appl. Pharmacol. 231 2 (2008) 248-259
37. Punt A., Paini A., Boersma M.G., Freidig A.P., Delatour T., Scholz G., Schilter B., van Bladeren P.J., and Rietjens I.M. Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats. Toxicol. Sci. 110 2 (2009) 255-269
38. Randerath K., Haglund R.E., Phillips D.H., and Reddy M.V. 32P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis 5 12 (1984) 1613-1622
39. Rietjens I.M., Boersma M.G., van der Woude H., Jeurissen S.M., Schutte M.E., and Alink G.M. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat. Res. 574 (2005) 124-138
40. Rietjens I.M.C.M., Slob W., Galli C., and Silano V. Risk assessment of botanical preparations intended for use in food and food supplements: Emerging issues. Toxicol. Letters 180 (2008) 130-136
41. Sangster S.A., Caldwell J., Anthony A., Hutt A.J., and Smith R.L. The metabolic disposition of [methoxy-14C]-labeled trans-anethole, estragole and p-propylanisole in human volunteers. Xenobiotica 17 (1987) 1223-1232
42. Schiestl R.H., Chan W.S., Gietz R.D., Mehta R.D., and Hastings P.J. Safrolee, eugenol and methyleugenol induce intrachromosomal recombination in yeast. Mutat. Res. 224 (1989) 427-436
43. Scientific Committee on Food (SCF), 2001. Opinion of the Scientific Committee on Food on Methyleugenol (4-Allyl-1,2-dimethoxybenzene) (Adopted on 26 September 2001). SCF/CS/FLAV/FLAVOUR/4 ADD1 FINAL 26 September 2001.
44. Sekizawa J., and Shibamoto T. Genotoxicity of safrolee-related chemicals in microbial test systems. Mutat. Res. 101 (1982) 127-140
45. Sharma R.A., Ireson C.R., Verschoyle R.D., Hill K.A., Williams M.L., Leuratti C., Manson M.M., Marnett L.J., Steward W.P., and Gescher A. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin. Cancer Res. 7 (2001) 1452-1458
46. Sheen L.Y., Tsai Ou Y.H., and Tsai S.J. Flavor characteristic compounds found in the essential oil of Ocimum basilicum L. with sensory evaluation and statistical analysis. J. Agric. Food Chem. 39 (1991) 939-943
47. Siano F., Ghizzoni G., Gionfriddo F., Colombo E., Servillo L., and Castaldo D. Determination of estragole, safrole and eugenol methyl ether in food products. Food Chem. 81 (2003) 469-475
48. Smith R.L., Adams T.B., Doull J., Feron V.J., Goodman J.I., Marnett L.J., Portoghese P.S., Waddell W.J., Wagner B.M., Rogers A.E., Caldwell J., and Sipes I.G. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyleugenol and estragole. Food Chem. Toxicol. 40 7 (2002) 851-870
49. Solheim E., and Scheline R.S. Metabolism of alkenebenzene derivatives in the rat. I. p-Methoxyallylbenzene (estragole) and p-methoxypropenylbenzene (anethole). Xenobiotica 3 8 (1973) 493-510
50. Swanson A.B., Miller E.C., and Miller J.A. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes. Biochim. Biophys. Acta 673 (1981) 504-516
51. To L.P., Hunt T.P., and Andersen M.E. Mutagenicity of transanethole, estragole, eugenol and safrolee in the Ames Salmonella typhimurium assay. Bull. Environ. Contamination Toxicol. 28 (1982) 647-654
52. Tsai, S.J., Sheen, L.Y., 1987. Essential oil of Ocimum basilicum L. cultivated in Taiwan. In: Sze, L.W., Woo, F.C. (Eds.), Trends in Food Science. Proceedings of the 7th World Congress of Food Science and Technology, Singapore. Institute of Food Science and Technology, Singapore, pp. 66-70.
53. Wakazono H., Gardner I., Eliasson E., Coughtrie M.W.H., Kenna J.G., and Caldwell J. Immunochemical identification of hepatic protein adducts derived from estragole. Chem. Res. Toxicol. 11 8 (1998) 863-872
54. Wiseman R.W., Miller E.C., Miller J.A., and Liem A. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J × C3H/HeJ F1 mice. Cancer Res. 47 9 (1987) 2275-2283
55. Zangouras A., Caldwell J., Hutt A.J., and Smith R.L. Dose dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite, 1′-hydroxyestragole. Biochem. Pharmacol. 30 (1981) 1383-1386